Meanwhile, M3R AA83-95 stimulation increased IFN- single producing Th1 cells compared with no stimulation, although the increase was also observed when stimulating with M3R control peptide (Physique 5B). which was analyzed and confirmed by coculture of isolated CD4+ T cells with antigen presenting cells plus M3R peptides in vitro, was peptide 83-95 of M3R. Peptide recognition was partly in an HLA-DRCrestricted manner, confirmed by blocking assay. M3R-reactive Th17 cells positivity correlated with higher titers of anti-M3R antibodies, whose systemic disease activity score tended to be higher. Our studies highlight the role of tissue-specific autoantigenCderived circulating Th17 cells in pSS, for which further work might lead to antigen-specific targeted therapy. = 0.03) (Physique 1 and Physique 2). Open in a separate window Physique 1 Representative photomicrographs of ELISpot assay.Peripheral blood mononuclear cells were incubated with a mixture of selected M3R peptides according to the HLA-DRB1 type of participants, M5R peptides (control peptides), or 1% PHA (positive control) for 40 hours. Five replicate wells were examined for each condition. Representative photomicrographs of M3R-reactive IL-17Cproducing cells in a negative pSS patient (pSS4), positive pSS patient (pSS5), HS (HS8), and IgG4-RD patient (IgG4-RD3) is usually shown. In patient pSS5, note the higher number of spots after stimulation with the indicated mixture of the selected M3R peptides, whereas no substantial increase in the spots was noted after M5R peptides stimulation. In patients pSS4, HS8, and IgG4-RD3, no spots were noted after stimulation with either M3R or M5R peptides. Open in a separate window Physique 2 Statistical analysis of spot counts between culture conditions.Ten pSS patients examined, and representative data of HS and IgG4-RD patients is usually shown. (A) Analysis of ELISpot of IL-17Cproducing cells in pSS (= 10). Results are expressed as mean spot counts of 5 replicate ELISpot microwells, each made up of 2.0 105 to 5.0 105 cells of PBMCs/well. Spot counts were compared between each condition (Kruskal-Wallis test, < 0.05). The numbers of spots increased significantly in pSS1, pSS3, pSS5, pSS8, and pSS9 after stimulation with M3R peptides, compared with no stimulation. (B and C) Representative ELISpot analysis of IL-17Cproducing cells in HS (= 10) (B) and IgG4-RD (= 5) (C) patients. The numbers of spots did not change in any of the subjects of the 2 2 groups after stimulation with the M3R peptides. *< 0.05, by Kruskal-Wallis test. Induction of M3R-reactive IL-17 secretion by M3R AA83-95 peptide. Based on the above findings, we KN-92 next sought to identify the main peptide responsible for triggering IL-17 secretion. For this purpose, a mixture of the selected top 10 10 ranked M3R peptides used for stimulation in the previous exam were separately used for stimulation of samples positive for M3R-specific IL-17Csecreting cells. By stimulating candidate M3R peptides separately, to our surprise, we found that 1 peptide, M3R AA83-95, brought on IL-17 secretion in all 5 pSS patients, and a significantly larger number of spots was noted after incubation of PBMCs with M3R peptides, compared with nonstimulation (Physique 3). One pSS patient (pSS8) with HLA-DRB1 09:01/15:01, also reacted to another peptide, M3R AA76-87. This indicates that recognition of M3R AA76-95 could be the trigger for IL-17 secretion because these 2 peptides have 7 overlapping amino acids. Despite the lack of statistical significance, another patient (pSS3), who also possessed HLA-DRB1 15:01 in common with pSS8, tended to show a larger number of spots after M3R AA76-87 peptide stimulation (Physique 3). Overall, these findings suggest that M3R-specific IL-17 secretion is usually induced mainly by M3R AA83-95 KN-92 and that these peptides were probably presented by several HLA alleles, including HLA-DRB1 15:01 in pSS patients. Open in a separate window Physique 3 Identification of the main M3R peptide responsible for IL-17 secretion.In this study, 2.5 105 to 5 105 cells/well of PBMCs from pSS CCNE2 patients positive for peripheral M3R-reactive IL-17 secreting cells were incubated separately with each of a mixture of KN-92 M3R peptides (12C20 amino acids components each) predicted to bind to each HLA-DRB1. We compared the number of counted spots for.